{"entity":{"type":"insider","cik":"0001460752","url":"/insider/0001460752","json_url":"/insider/0001460752.json","name":"NEA Partners 13, Limited Partnership","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":47,"n_filings":27,"first":"2011-11-22","last":"2025-03-14","span_basis":"filed_date"},"name_variants":[{"name":"NEA Partners 13, Limited Partnership","source":"filing","n_filings":27,"first_seen":"2011-11-22","last_seen":"2025-03-14"}],"transactions":[{"id":4791358,"accession":"0000950170-25-039628","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-039628","line_url":"/filing/0000950170-25-039628#line-3","is_derivative":false,"issuer_cik":"0001237289","issuer_name":"BuzzFeed, Inc.","issuer_ticker":"BZFD","issuer_name_source":null,"issuer_url":"/issuer/0001237289","owner_cik":null,"owner_name":"BASKETT FOREST; NEA 13 GP, Ltd; NEA Partners 13, Limited Partnership; NEW ENTERPRISE ASSOCIATES 13 LP; SANDELL SCOTT D","owner_display_name":"BASKETT FOREST","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":273246.0,"shares_display":"273,246","price_per_share":2.2631,"price_display":"2.26","price_state":"stated","total_value":618383.0226,"total_display":"618,383.02","total_whole":"618,383","shares_owned_after":3401499.0,"shares_owned_after_display":"3,401,499","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-14","filed_date":"2025-03-14","scope":"insider"},{"id":4791355,"accession":"0000950170-25-039628","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-039628","line_url":"/filing/0000950170-25-039628#line-2","is_derivative":false,"issuer_cik":"0001237289","issuer_name":"BuzzFeed, Inc.","issuer_ticker":"BZFD","issuer_name_source":null,"issuer_url":"/issuer/0001237289","owner_cik":null,"owner_name":"BASKETT FOREST; NEA 13 GP, Ltd; NEA Partners 13, Limited Partnership; NEW ENTERPRISE ASSOCIATES 13 LP; SANDELL SCOTT D","owner_display_name":"BASKETT FOREST","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61448.0,"shares_display":"61,448","price_per_share":2.0142,"price_display":"2.01","price_state":"stated","total_value":123768.5616,"total_display":"123,768.56","total_whole":"123,769","shares_owned_after":3674745.0,"shares_owned_after_display":"3,674,745","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-13","filed_date":"2025-03-14","scope":"insider"},{"id":4791351,"accession":"0000950170-25-039628","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-039628","line_url":"/filing/0000950170-25-039628#line-1","is_derivative":false,"issuer_cik":"0001237289","issuer_name":"BuzzFeed, Inc.","issuer_ticker":"BZFD","issuer_name_source":null,"issuer_url":"/issuer/0001237289","owner_cik":null,"owner_name":"BASKETT FOREST; NEA 13 GP, Ltd; NEA Partners 13, Limited Partnership; NEW ENTERPRISE ASSOCIATES 13 LP; SANDELL SCOTT D","owner_display_name":"BASKETT FOREST","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28272.0,"shares_display":"28,272","price_per_share":1.9756,"price_display":"1.98","price_state":"stated","total_value":55854.1632,"total_display":"55,854.16","total_whole":"55,854","shares_owned_after":3736193.0,"shares_owned_after_display":"3,736,193","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-12","filed_date":"2025-03-14","scope":"insider"},{"id":4416998,"accession":"0000950170-25-037454","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-037454","line_url":"/filing/0000950170-25-037454#line-2","is_derivative":false,"issuer_cik":"0001237289","issuer_name":"BuzzFeed, Inc.","issuer_ticker":"BZFD","issuer_name_source":null,"issuer_url":"/issuer/0001237289","owner_cik":null,"owner_name":"BASKETT FOREST; NEA 13 GP, Ltd; NEA Partners 13, Limited Partnership; NEW ENTERPRISE ASSOCIATES 13 LP; SANDELL SCOTT D","owner_display_name":"BASKETT FOREST","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13629.0,"shares_display":"13,629","price_per_share":1.9532,"price_display":"1.95","price_state":"stated","total_value":26620.1628,"total_display":"26,620.16","total_whole":"26,620","shares_owned_after":3764465.0,"shares_owned_after_display":"3,764,465","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-11","filed_date":"2025-03-11","scope":"insider"},{"id":4416994,"accession":"0000950170-25-037454","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-037454","line_url":"/filing/0000950170-25-037454#line-1","is_derivative":false,"issuer_cik":"0001237289","issuer_name":"BuzzFeed, Inc.","issuer_ticker":"BZFD","issuer_name_source":null,"issuer_url":"/issuer/0001237289","owner_cik":null,"owner_name":"BASKETT FOREST; NEA 13 GP, Ltd; NEA Partners 13, Limited Partnership; NEW ENTERPRISE ASSOCIATES 13 LP; SANDELL SCOTT D","owner_display_name":"BASKETT FOREST","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33848.0,"shares_display":"33,848","price_per_share":2.0563,"price_display":"2.06","price_state":"stated","total_value":69601.6424,"total_display":"69,601.64","total_whole":"69,602","shares_owned_after":3778094.0,"shares_owned_after_display":"3,778,094","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-07","filed_date":"2025-03-11","scope":"insider"},{"id":4099887,"accession":"0000950170-25-035077","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-035077","line_url":"/filing/0000950170-25-035077#line-3","is_derivative":false,"issuer_cik":"0001237289","issuer_name":"BuzzFeed, Inc.","issuer_ticker":"BZFD","issuer_name_source":null,"issuer_url":"/issuer/0001237289","owner_cik":null,"owner_name":"BASKETT FOREST; NEA 13 GP, Ltd; NEA Partners 13, Limited Partnership; NEW ENTERPRISE ASSOCIATES 13 LP; SANDELL SCOTT D","owner_display_name":"BASKETT FOREST","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11127.0,"shares_display":"11,127","price_per_share":2.1005,"price_display":"2.10","price_state":"stated","total_value":23372.2635,"total_display":"23,372.26","total_whole":"23,372","shares_owned_after":3811942.0,"shares_owned_after_display":"3,811,942","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-06","filed_date":"2025-03-06","scope":"insider"},{"id":4099883,"accession":"0000950170-25-035077","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-035077","line_url":"/filing/0000950170-25-035077#line-2","is_derivative":false,"issuer_cik":"0001237289","issuer_name":"BuzzFeed, Inc.","issuer_ticker":"BZFD","issuer_name_source":null,"issuer_url":"/issuer/0001237289","owner_cik":null,"owner_name":"BASKETT FOREST; NEA 13 GP, Ltd; NEA Partners 13, Limited Partnership; NEW ENTERPRISE ASSOCIATES 13 LP; SANDELL SCOTT D","owner_display_name":"BASKETT FOREST","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8966.0,"shares_display":"8,966","price_per_share":2.0372,"price_display":"2.04","price_state":"stated","total_value":18265.5352,"total_display":"18,265.54","total_whole":"18,266","shares_owned_after":3823069.0,"shares_owned_after_display":"3,823,069","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-06","scope":"insider"},{"id":4099878,"accession":"0000950170-25-035077","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-035077","line_url":"/filing/0000950170-25-035077#line-1","is_derivative":false,"issuer_cik":"0001237289","issuer_name":"BuzzFeed, Inc.","issuer_ticker":"BZFD","issuer_name_source":null,"issuer_url":"/issuer/0001237289","owner_cik":null,"owner_name":"BASKETT FOREST; NEA 13 GP, Ltd; NEA Partners 13, Limited Partnership; NEW ENTERPRISE ASSOCIATES 13 LP; SANDELL SCOTT D","owner_display_name":"BASKETT FOREST","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1438.0,"shares_display":"1,438","price_per_share":2.071,"price_display":"2.07","price_state":"stated","total_value":2978.098,"total_display":"2,978.10","total_whole":"2,978","shares_owned_after":3832035.0,"shares_owned_after_display":"3,832,035","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-06","scope":"insider"},{"id":8334213,"accession":"0001209191-23-042970","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-042970","line_url":"/filing/0001209191-23-042970#line-5","is_derivative":false,"issuer_cik":"0001235112","issuer_name":"Sagimet Biosciences Inc.","issuer_ticker":"SGMT","issuer_name_source":null,"issuer_url":"/issuer/0001235112","owner_cik":null,"owner_name":"NEW ENTERPRISE ASSOCIATES 13 LP; BASKETT FOREST; NEA Partners 13, Limited Partnership; SANDELL SCOTT D; KERINS PATRICK J; NEA 13 GP, Ltd","owner_display_name":"NEW ENTERPRISE ASSOCIATES 13 LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Series A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":662.0,"shares_display":"662","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":10592.0,"total_display":"10,592.00","total_whole":"10,592","shares_owned_after":3820275.0,"shares_owned_after_display":"3,820,275","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-18","filed_date":"2023-07-20","scope":"insider"},{"id":8334210,"accession":"0001209191-23-042970","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-042970","line_url":"/filing/0001209191-23-042970#line-4","is_derivative":false,"issuer_cik":"0001235112","issuer_name":"Sagimet Biosciences Inc.","issuer_ticker":"SGMT","issuer_name_source":null,"issuer_url":"/issuer/0001235112","owner_cik":null,"owner_name":"NEW ENTERPRISE ASSOCIATES 13 LP; BASKETT FOREST; NEA Partners 13, Limited Partnership; SANDELL SCOTT D; KERINS PATRICK J; NEA 13 GP, Ltd","owner_display_name":"NEW ENTERPRISE ASSOCIATES 13 LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Series A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":480000.0,"total_display":"480,000.00","total_whole":"480,000","shares_owned_after":3850275.0,"shares_owned_after_display":"3,850,275","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-18","filed_date":"2023-07-20","scope":"insider"},{"id":7830279,"accession":"0001209191-23-008574","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-008574","line_url":"/filing/0001209191-23-008574#line-1","is_derivative":false,"issuer_cik":"0001235112","issuer_name":"MINERVA SURGICAL INC","issuer_ticker":"UTRS","issuer_name_source":null,"issuer_url":"/issuer/0001235112","owner_cik":null,"owner_name":"NEA 13 GP, Ltd; NEW ENTERPRISE ASSOCIATES 13 LP; SANDELL SCOTT D; BASKETT FOREST; KERINS PATRICK J; NEA Partners 13, Limited Partnership","owner_display_name":"NEA 13 GP, Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":24437927.0,"shares_display":"24,437,927","price_per_share":0.2046,"price_display":"0.20","price_state":"stated","total_value":4999999.8642,"total_display":"4,999,999.86","total_whole":"5,000,000","shares_owned_after":34437052.0,"shares_owned_after_display":"34,437,052","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-09","filed_date":"2023-02-10","scope":"insider"},{"id":6957330,"accession":"0001209191-22-054647","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-054647","line_url":"/filing/0001209191-22-054647#line-1","is_derivative":false,"issuer_cik":"0001169245","issuer_name":"PhaseBio Pharmaceuticals Inc","issuer_ticker":"PHAS","issuer_name_source":null,"issuer_url":"/issuer/0001169245","owner_cik":null,"owner_name":"NEA 13 GP, Ltd; NEW ENTERPRISE ASSOCIATES 13 LP; NEA Partners 13, Limited Partnership; SANDELL SCOTT D; BASKETT FOREST; KERINS PATRICK J","owner_display_name":"NEA 13 GP, Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1784109.0,"shares_display":"1,784,109","price_per_share":0.147,"price_display":"0.15","price_state":"stated","total_value":262264.023,"total_display":"262,264.02","total_whole":"262,264","shares_owned_after":4857525.0,"shares_owned_after_display":"4,857,525","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-25","filed_date":"2022-10-26","scope":"insider"},{"id":5384741,"accession":"0001209191-21-061994","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-061994","line_url":"/filing/0001209191-21-061994#line-5","is_derivative":false,"issuer_cik":"0001235112","issuer_name":"MINERVA SURGICAL INC","issuer_ticker":"UTRS","issuer_name_source":null,"issuer_url":"/issuer/0001235112","owner_cik":null,"owner_name":"SANDELL SCOTT D; NEA Partners 13, Limited Partnership; BASKETT FOREST; KERINS PATRICK J; NEA 13 GP, Ltd; NEW ENTERPRISE ASSOCIATES 13 LP","owner_display_name":"SANDELL SCOTT D","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1300000.0,"shares_display":"1,300,000","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":15600000.0,"total_display":"15,600,000.00","total_whole":"15,600,000","shares_owned_after":9999125.0,"shares_owned_after_display":"9,999,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-26","filed_date":"2021-10-28","scope":"insider"},{"id":2684670,"accession":"0001209191-20-047101","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-047101","line_url":"/filing/0001209191-20-047101","is_derivative":false,"issuer_cik":"0001235112","issuer_name":"Sprout Social, Inc.","issuer_ticker":"SPT","issuer_name_source":null,"issuer_url":"/issuer/0001235112","owner_cik":null,"owner_name":"KERINS PATRICK J; NEA 13 GP, Ltd; BASKETT FOREST; NEA Partners 13, Limited Partnership; NEW ENTERPRISE ASSOCIATES 13 LP; SANDELL SCOTT D","owner_display_name":"KERINS PATRICK J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3441846.0,"shares_display":"3,441,846","price_per_share":27.5,"price_display":"27.50","price_state":"stated","total_value":94650765.0,"total_display":"94,650,765.00","total_whole":"94,650,765","shares_owned_after":6031790.0,"shares_owned_after_display":"6,031,790","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-17","filed_date":"2020-08-18","scope":"insider","n_lines":2},{"id":6730738,"accession":"0001209191-18-062803","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-062803","line_url":"/filing/0001209191-18-062803#line-1","is_derivative":false,"issuer_cik":"0001005561","issuer_name":"Ra Pharmaceuticals, Inc.","issuer_ticker":"RARX","issuer_name_source":null,"issuer_url":"/issuer/0001005561","owner_cik":null,"owner_name":"SANDELL SCOTT D; NEA Partners 13, Limited Partnership; BASKETT FOREST; NEW ENTERPRISE ASSOCIATES 13 LP; NEA 13 GP, Ltd; KERINS PATRICK J; MOTT DAVID M; BARRIS PETER J","owner_display_name":"SANDELL SCOTT D","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":645161.0,"shares_display":"645,161","price_per_share":15.5,"price_display":"15.50","price_state":"stated","total_value":9999995.5,"total_display":"9,999,995.50","total_whole":"9,999,996","shares_owned_after":6135234.0,"shares_owned_after_display":"6,135,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-14","filed_date":"2018-12-14","scope":"insider"},{"id":6156574,"accession":"0001209191-18-056072","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-056072","line_url":"/filing/0001209191-18-056072#line-2","is_derivative":false,"issuer_cik":"0001005561","issuer_name":"PhaseBio Pharmaceuticals Inc","issuer_ticker":"PHAS","issuer_name_source":null,"issuer_url":"/issuer/0001005561","owner_cik":null,"owner_name":"KERINS PATRICK J; NEA 13 GP, Ltd; NEW ENTERPRISE ASSOCIATES 13 LP; BARRIS PETER J; SANDELL SCOTT D; NEA Partners 13, Limited Partnership; BASKETT FOREST; BARRETT M JAMES; Viswanathan Ravi; MOTT DAVID M","owner_display_name":"KERINS PATRICK J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1800000.0,"shares_display":"1,800,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":9000000.0,"total_display":"9,000,000.00","total_whole":"9,000,000","shares_owned_after":6641634.0,"shares_owned_after_display":"6,641,634","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-10-22","filed_date":"2018-10-24","scope":"insider"},{"id":6658296,"accession":"0001209191-18-017562","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-18-017562","line_url":"/filing/0001209191-18-017562#line-8","is_derivative":false,"issuer_cik":"0001452907","issuer_name":"TESARO, Inc.","issuer_ticker":"TSRO","issuer_name_source":null,"issuer_url":"/issuer/0001452907","owner_cik":null,"owner_name":"NEA Partners 13, Limited Partnership; NEA 13 GP, Ltd; NEW ENTERPRISE ASSOCIATES 13 LP","owner_display_name":"NEA Partners 13, Limited Partnership","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12634.0,"shares_display":"12,634","price_per_share":59.8154,"price_display":"59.82","price_state":"stated","total_value":755707.7636,"total_display":"755,707.76","total_whole":"755,708","shares_owned_after":9681129.0,"shares_owned_after_display":"9,681,129","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-06","filed_date":"2018-03-06","scope":"insider"},{"id":6658294,"accession":"0001209191-18-017562","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-18-017562","line_url":"/filing/0001209191-18-017562","is_derivative":false,"issuer_cik":"0001452907","issuer_name":"TESARO, Inc.","issuer_ticker":"TSRO","issuer_name_source":null,"issuer_url":"/issuer/0001452907","owner_cik":null,"owner_name":"NEA Partners 13, Limited Partnership; NEA 13 GP, Ltd; NEW ENTERPRISE ASSOCIATES 13 LP","owner_display_name":"NEA Partners 13, Limited Partnership","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":49169.0,"shares_display":"49,169","price_per_share":58.82974807500661,"price_display":"58.83","price_state":"stated","total_value":2892599.8831,"total_display":"2,892,599.88","total_whole":"2,892,600","shares_owned_after":9649647.0,"shares_owned_after_display":"9,649,647","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-05","filed_date":"2018-03-06","scope":"insider","n_lines":3},{"id":6658286,"accession":"0001209191-18-017562","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-017562","line_url":"/filing/0001209191-18-017562","is_derivative":false,"issuer_cik":"0001452907","issuer_name":"TESARO, Inc.","issuer_ticker":"TSRO","issuer_name_source":null,"issuer_url":"/issuer/0001452907","owner_cik":null,"owner_name":"NEA Partners 13, Limited Partnership; NEA 13 GP, Ltd; NEW ENTERPRISE ASSOCIATES 13 LP","owner_display_name":"NEA Partners 13, Limited Partnership","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":54642.0,"shares_display":"54,642","price_per_share":55.56474119907763,"price_display":"55.56","price_state":"stated","total_value":3036168.5886,"total_display":"3,036,168.59","total_whole":"3,036,169","shares_owned_after":9590988.0,"shares_owned_after_display":"9,590,988","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-02","filed_date":"2018-03-06","scope":"insider","n_lines":4},{"id":5959880,"accession":"0001209191-18-011903","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-011903","line_url":"/filing/0001209191-18-011903#line-1","is_derivative":false,"issuer_cik":"0001005561","issuer_name":"Ra Pharmaceuticals, Inc.","issuer_ticker":"RARX","issuer_name_source":null,"issuer_url":"/issuer/0001005561","owner_cik":null,"owner_name":"MOTT DAVID M; NEW ENTERPRISE ASSOCIATES 13 LP; NEA 13 GP, Ltd; BARRETT M JAMES; NEA Partners 13, Limited Partnership; KERINS PATRICK J; BASKETT FOREST; Viswanathan Ravi; BARRIS PETER J; SANDELL SCOTT D","owner_display_name":"MOTT DAVID M","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000000.0,"shares_display":"2,000,000","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":12000000.0,"total_display":"12,000,000.00","total_whole":"12,000,000","shares_owned_after":5490073.0,"shares_owned_after_display":"5,490,073","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-16","filed_date":"2018-02-21","scope":"insider"},{"id":5176897,"accession":"0001209191-17-056453","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-056453","line_url":"/filing/0001209191-17-056453#line-3","is_derivative":false,"issuer_cik":"0001452907","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001452907","owner_cik":null,"owner_name":"NEA Partners 13, Limited Partnership; NEW ENTERPRISE ASSOCIATES 13 LP; NEA 13 GP, Ltd","owner_display_name":"NEA Partners 13, Limited Partnership","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":550000.0,"shares_display":"550,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":9350000.0,"total_display":"9,350,000.00","total_whole":"9,350,000","shares_owned_after":4909956.0,"shares_owned_after_display":"4,909,956","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-10","filed_date":"2017-10-10","scope":"insider"},{"id":2378396,"accession":"0001209191-16-147480","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-16-147480","line_url":"/filing/0001209191-16-147480#line-5","is_derivative":false,"issuer_cik":"0001452907","issuer_name":"Ra Pharmaceuticals, Inc.","issuer_ticker":"RARX","issuer_name_source":null,"issuer_url":"/issuer/0001452907","owner_cik":null,"owner_name":"NEA Partners 13, Limited Partnership; NEA 13 GP, Ltd; NEW ENTERPRISE ASSOCIATES 13 LP","owner_display_name":"NEA Partners 13, Limited Partnership","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":435.0,"shares_display":"435","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":5655.0,"total_display":"5,655.00","total_whole":"5,655","shares_owned_after":80223.0,"shares_owned_after_display":"80,223","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-31","filed_date":"2016-10-31","scope":"insider"},{"id":2378391,"accession":"0001209191-16-147480","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-147480","line_url":"/filing/0001209191-16-147480#line-4","is_derivative":false,"issuer_cik":"0001452907","issuer_name":"Ra Pharmaceuticals, Inc.","issuer_ticker":"RARX","issuer_name_source":null,"issuer_url":"/issuer/0001452907","owner_cik":null,"owner_name":"NEA Partners 13, Limited Partnership; NEA 13 GP, Ltd; NEW ENTERPRISE ASSOCIATES 13 LP","owner_display_name":"NEA Partners 13, Limited Partnership","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":338462.0,"shares_display":"338,462","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":4400006.0,"total_display":"4,400,006.00","total_whole":"4,400,006","shares_owned_after":3490073.0,"shares_owned_after_display":"3,490,073","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-31","filed_date":"2016-10-31","scope":"insider"},{"id":2697850,"accession":"0001209191-16-109537","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-109537","line_url":"/filing/0001209191-16-109537#line-1","is_derivative":false,"issuer_cik":"0001452907","issuer_name":"TESARO, Inc.","issuer_ticker":"TSRO","issuer_name_source":null,"issuer_url":"/issuer/0001452907","owner_cik":null,"owner_name":"NEA 13 GP, Ltd; NEA Partners 13, Limited Partnership; NEW ENTERPRISE ASSOCIATES 13 LP","owner_display_name":"NEA 13 GP, Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":710429.0,"shares_display":"710,429","price_per_share":35.19,"price_display":"35.19","price_state":"stated","total_value":24999996.51,"total_display":"24,999,996.51","total_whole":"24,999,997","shares_owned_after":9564684.0,"shares_owned_after_display":"9,564,684","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-18","filed_date":"2016-03-18","scope":"insider"},{"id":2770254,"accession":"0001209191-16-091059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-091059","line_url":"/filing/0001209191-16-091059#line-1","is_derivative":false,"issuer_cik":"0001452907","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001452907","owner_cik":null,"owner_name":"NEA 13 GP, Ltd; NEW ENTERPRISE ASSOCIATES 13 LP; NEA Partners 13, Limited Partnership","owner_display_name":"NEA 13 GP, Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1111111.0,"shares_display":"1,111,111","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":9999999.0,"total_display":"9,999,999.00","total_whole":"9,999,999","shares_owned_after":5854351.0,"shares_owned_after_display":"5,854,351","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-12","filed_date":"2016-01-12","scope":"insider"},{"id":6436672,"accession":"0001181431-14-034002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-034002","line_url":"/filing/0001181431-14-034002#line-2","is_derivative":false,"issuer_cik":"0001452907","issuer_name":"Dermira, Inc.","issuer_ticker":"DERM","issuer_name_source":null,"issuer_url":"/issuer/0001452907","owner_cik":null,"owner_name":"NEA 13 GP, Ltd; NEA Partners 13, Limited Partnership; NEW ENTERPRISE ASSOCIATES 13 LP","owner_display_name":"NEA 13 GP, Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":69112.0,"shares_display":"69,112","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":1105792.0,"total_display":"1,105,792.00","total_whole":"1,105,792","shares_owned_after":3502922.0,"shares_owned_after_display":"3,502,922","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-08","filed_date":"2014-10-08","scope":"insider"},{"id":6906153,"accession":"0001181431-14-027151","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-14-027151","line_url":"/filing/0001181431-14-027151#line-5","is_derivative":false,"issuer_cik":"0001452907","issuer_name":"Roka BioScience, Inc.","issuer_ticker":"ROKA","issuer_name_source":null,"issuer_url":"/issuer/0001452907","owner_cik":null,"owner_name":"NEA 13 GP, Ltd; NEW ENTERPRISE ASSOCIATES 13 LP; NEA Partners 13, Limited Partnership","owner_display_name":"NEA 13 GP, Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":383333.0,"shares_display":"383,333","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":4599996.0,"total_display":"4,599,996.00","total_whole":"4,599,996","shares_owned_after":3216810.0,"shares_owned_after_display":"3,216,810","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-22","filed_date":"2014-07-22","scope":"insider"},{"id":6640550,"accession":"0001181431-14-003480","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-003480","line_url":"/filing/0001181431-14-003480#line-1","is_derivative":false,"issuer_cik":"0001122897","issuer_name":"CVENT INC","issuer_ticker":"CVT","issuer_name_source":null,"issuer_url":"/issuer/0001122897","owner_cik":null,"owner_name":"NEA Partners 13, Limited Partnership; NEW ENTERPRISE ASSOCIATES 13 LP; NEA 13 GP, Ltd","owner_display_name":"NEA Partners 13, Limited Partnership","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":169887.0,"shares_display":"169,887","price_per_share":35.5,"price_display":"35.50","price_state":"stated","total_value":6030988.5,"total_display":"6,030,988.50","total_whole":"6,030,989","shares_owned_after":5994106.0,"shares_owned_after_display":"5,994,106","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-21","filed_date":"2014-01-23","scope":"insider"},{"id":6253238,"accession":"0001181431-14-003123","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-003123","line_url":"/filing/0001181431-14-003123#line-1","is_derivative":false,"issuer_cik":"0001122897","issuer_name":"CVENT INC","issuer_ticker":"CVT","issuer_name_source":null,"issuer_url":"/issuer/0001122897","owner_cik":null,"owner_name":"NEA Partners 13, Limited Partnership; NEA 13 GP, Ltd; NEW ENTERPRISE ASSOCIATES 13 LP","owner_display_name":"NEA Partners 13, Limited Partnership","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1132589.0,"shares_display":"1,132,589","price_per_share":35.5,"price_display":"35.50","price_state":"stated","total_value":40206909.5,"total_display":"40,206,909.50","total_whole":"40,206,910","shares_owned_after":6163993.0,"shares_owned_after_display":"6,163,993","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-16","filed_date":"2014-01-21","scope":"insider"},{"id":7049999,"accession":"0001181431-14-002531","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-002531","line_url":"/filing/0001181431-14-002531#line-2","is_derivative":false,"issuer_cik":"0001219871","issuer_name":"GLYCOMIMETICS INC","issuer_ticker":"GLYC","issuer_name_source":null,"issuer_url":"/issuer/0001219871","owner_cik":null,"owner_name":"KOLLURI KRISHNA KITTU; NEA Partners 13, Limited Partnership; MOTT DAVID M; Viswanathan Ravi; KERINS PATRICK J; NEW ENTERPRISE ASSOCIATES 13 LP; NEA 13 GP, Ltd; Weller Harry R; DRANT RYAN D; BASKETT FOREST","owner_display_name":"KOLLURI KRISHNA KITTU","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":512500.0,"shares_display":"512,500","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":4100000.0,"total_display":"4,100,000.00","total_whole":"4,100,000","shares_owned_after":4093377.0,"shares_owned_after_display":"4,093,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-15","filed_date":"2014-01-15","scope":"insider"},{"id":4483136,"accession":"0001181431-13-059373","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-13-059373","line_url":"/filing/0001181431-13-059373","is_derivative":false,"issuer_cik":"0001452907","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001452907","owner_cik":null,"owner_name":"NEA 13 GP, Ltd; NEA Partners 13, Limited Partnership; NEW ENTERPRISE ASSOCIATES 13 LP","owner_display_name":"NEA 13 GP, Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":49500.0,"shares_display":"49,500","price_per_share":19.78694727272727,"price_display":"19.79","price_state":"stated","total_value":979453.89,"total_display":"979,453.89","total_whole":"979,454","shares_owned_after":406500.0,"shares_owned_after_display":"406,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-15","filed_date":"2013-11-18","scope":"insider","n_lines":2},{"id":4483125,"accession":"0001181431-13-059373","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-13-059373","line_url":"/filing/0001181431-13-059373","is_derivative":false,"issuer_cik":"0001452907","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001452907","owner_cik":null,"owner_name":"NEA 13 GP, Ltd; NEA Partners 13, Limited Partnership; NEW ENTERPRISE ASSOCIATES 13 LP","owner_display_name":"NEA 13 GP, Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":357000.0,"shares_display":"357,000","price_per_share":19.659738851540617,"price_display":"19.66","price_state":"stated","total_value":7018526.77,"total_display":"7,018,526.77","total_whole":"7,018,527","shares_owned_after":357000.0,"shares_owned_after_display":"357,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-14","filed_date":"2013-11-18","scope":"insider","n_lines":3},{"id":5506567,"accession":"0001181431-13-033511","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-033511","line_url":"/filing/0001181431-13-033511#line-2","is_derivative":false,"issuer_cik":"0001452907","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001452907","owner_cik":null,"owner_name":"NEA 13 GP, Ltd; NEA Partners 13, Limited Partnership; NEW ENTERPRISE ASSOCIATES 13 LP","owner_display_name":"NEA 13 GP, Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400000.0,"shares_display":"400,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":6000000.0,"total_display":"6,000,000.00","total_whole":"6,000,000","shares_owned_after":6033240.0,"shares_owned_after_display":"6,033,240","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-05","filed_date":"2013-06-07","scope":"insider"},{"id":5390199,"accession":"0001181431-13-022601","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-13-022601","line_url":"/filing/0001181431-13-022601#line-5","is_derivative":false,"issuer_cik":"0001452907","issuer_name":"Omthera Pharmaceuticals, Inc.","issuer_ticker":"OMTH","issuer_name_source":null,"issuer_url":"/issuer/0001452907","owner_cik":null,"owner_name":"NEW ENTERPRISE ASSOCIATES 13 LP; NEA 13 GP, Ltd; NEA Partners 13, Limited Partnership","owner_display_name":"NEW ENTERPRISE ASSOCIATES 13 LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":196.0,"shares_display":"196","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":1568.0,"total_display":"1,568.00","total_whole":"1,568","shares_owned_after":156054.0,"shares_owned_after_display":"156,054","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-16","filed_date":"2013-04-17","scope":"insider"},{"id":5390195,"accession":"0001181431-13-022601","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-13-022601","line_url":"/filing/0001181431-13-022601#line-4","is_derivative":false,"issuer_cik":"0001452907","issuer_name":"Omthera Pharmaceuticals, Inc.","issuer_ticker":"OMTH","issuer_name_source":null,"issuer_url":"/issuer/0001452907","owner_cik":null,"owner_name":"NEW ENTERPRISE ASSOCIATES 13 LP; NEA 13 GP, Ltd; NEA Partners 13, Limited Partnership","owner_display_name":"NEW ENTERPRISE ASSOCIATES 13 LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":625000.0,"shares_display":"625,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":5833213.0,"shares_owned_after_display":"5,833,213","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-16","filed_date":"2013-04-17","scope":"insider"},{"id":2504591,"accession":"0001181431-12-055843","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-055843","line_url":"/filing/0001181431-12-055843#line-1","is_derivative":false,"issuer_cik":"0001372375","issuer_name":"Millennial Media Inc.","issuer_ticker":"MM","issuer_name_source":null,"issuer_url":"/issuer/0001372375","owner_cik":null,"owner_name":"NEA 13 GP, Ltd; NEA Partners 13, Limited Partnership; NEW ENTERPRISE ASSOCIATES 13 LP","owner_display_name":"NEA 13 GP, Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1597787.0,"shares_display":"1,597,787","price_per_share":13.4425,"price_display":"13.44","price_state":"stated","total_value":21478251.7475,"total_display":"21,478,251.75","total_whole":"21,478,252","shares_owned_after":8196614.0,"shares_owned_after_display":"8,196,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-10-29","filed_date":"2012-10-30","scope":"insider"},{"id":3235991,"accession":"0001181431-12-039183","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-12-039183","line_url":"/filing/0001181431-12-039183#line-2","is_derivative":false,"issuer_cik":"0001452907","issuer_name":"TESARO, Inc.","issuer_ticker":"TSRO","issuer_name_source":null,"issuer_url":"/issuer/0001452907","owner_cik":null,"owner_name":"NEA Partners 13, Limited Partnership; NEW ENTERPRISE ASSOCIATES 13 LP; NEA 13 GP, Ltd","owner_display_name":"NEA Partners 13, Limited Partnership","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1111111.0,"shares_display":"1,111,111","price_per_share":13.5,"price_display":"13.50","price_state":"stated","total_value":14999998.5,"total_display":"14,999,998.50","total_whole":"14,999,999","shares_owned_after":11499255.0,"shares_owned_after_display":"11,499,255","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-03","filed_date":"2012-07-03","scope":"insider"},{"id":9149505,"accession":"0001181431-11-057256","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-11-057256","line_url":"/filing/0001181431-11-057256#line-3","is_derivative":false,"issuer_cik":"0001452907","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001452907","owner_cik":null,"owner_name":"NEA 13 GP, Ltd; NEW ENTERPRISE ASSOCIATES 13 LP; NEA Partners 13, Limited Partnership","owner_display_name":"NEA 13 GP, Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1316299.0,"shares_display":"1,316,299","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":17111887.0,"total_display":"17,111,887.00","total_whole":"17,111,887","shares_owned_after":3419671.0,"shares_owned_after_display":"3,419,671","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-21","filed_date":"2011-11-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001828972","name":"BuzzFeed, Inc.","url":"/issuer/0001828972","role":"Ten percent owner","n_filings":3,"first_seen":"2025-03-06","last_seen":"2025-03-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001400118","name":"Sagimet Biosciences Inc.","url":"/issuer/0001400118","role":"Ten percent owner","n_filings":1,"first_seen":"2023-07-20","last_seen":"2023-07-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001452965","name":"MINERVA SURGICAL INC","url":"/issuer/0001452965","role":"Ten percent owner","n_filings":2,"first_seen":"2021-10-28","last_seen":"2023-02-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001169245","name":"PhaseBio Pharmaceuticals Inc","url":"/issuer/0001169245","role":"Ten percent owner","n_filings":2,"first_seen":"2018-10-24","last_seen":"2022-10-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001517375","name":"Sprout Social, Inc.","url":"/issuer/0001517375","role":"Ten percent owner","n_filings":1,"first_seen":"2020-08-18","last_seen":"2020-08-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001481512","name":"Ra Pharmaceuticals, Inc.","url":"/issuer/0001481512","role":"Ten percent owner","n_filings":3,"first_seen":"2016-10-31","last_seen":"2018-12-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001491576","name":"TESARO, Inc.","url":"/issuer/0001491576","role":"Ten percent owner","n_filings":3,"first_seen":"2012-07-03","last_seen":"2018-03-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001649904","name":"RHYTHM PHARMACEUTICALS, INC.","url":"/issuer/0001649904","role":"Ten percent owner","n_filings":1,"first_seen":"2017-10-10","last_seen":"2017-10-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001571498","name":"Epizyme, Inc.","url":"/issuer/0001571498","role":"Ten percent owner","n_filings":3,"first_seen":"2013-06-07","last_seen":"2016-01-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001557883","name":"Dermira, Inc.","url":"/issuer/0001557883","role":"Ten percent owner","n_filings":1,"first_seen":"2014-10-08","last_seen":"2014-10-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001472343","name":"Roka BioScience, Inc.","url":"/issuer/0001472343","role":"Ten percent owner","n_filings":1,"first_seen":"2014-07-22","last_seen":"2014-07-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001122897","name":"CVENT INC","url":"/issuer/0001122897","role":"Ten percent owner","n_filings":2,"first_seen":"2014-01-21","last_seen":"2014-01-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001253689","name":"GLYCOMIMETICS INC","url":"/issuer/0001253689","role":"Ten percent owner","n_filings":1,"first_seen":"2014-01-15","last_seen":"2014-01-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001477598","name":"Omthera Pharmaceuticals, Inc.","url":"/issuer/0001477598","role":"Ten percent owner","n_filings":1,"first_seen":"2013-04-17","last_seen":"2013-04-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001372375","name":"Millennial Media Inc.","url":"/issuer/0001372375","role":"Ten percent owner","n_filings":1,"first_seen":"2012-10-30","last_seen":"2012-10-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001466301","name":"Clovis Oncology, Inc.","url":"/issuer/0001466301","role":"Ten percent owner","n_filings":1,"first_seen":"2011-11-22","last_seen":"2011-11-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001460752","retrieved_at":"2026-08-24T12:53:37+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}